ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Comment period for biospecimen network proposal extended.

January 16, 2004

ACS Adopts Principles As Basis For Reform Of Health Care System

July 17, 1992

NCI to Suggest Changes In Cooperative Group Terms of Award At Chairman’s Meeting Next Week

November 18, 1988

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

April 2, 1976

Cornel Student Withdraws In Wake Of Discrepancies Found In Study

September 18, 1981